pembrolizumab
merck
['pembro', 'cml']
 et al - pembro in chemo unfit elderly chl 25 pts, med age 77, comorbid pembro mono cmr 32%, pmr 40% generally low immune tox response to subsequent chemo quite good
attractive option
#icml23 #17icml 
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.